Company profile
ManifestSeven Holdings Corporation
OTC: MNFSF · Healthcare · Drug Manufacturers - Specialty & Generic
#568 of 1,422 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 22
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ Piotroski F, market scale
Methodology →Revenue TTM
$15.9M
Rev growth YoY (TTM)
-9.7%
Net income (FY)
-$66.4M
Employees
14
as of 2026-07-12
Market cap
$1.7k
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$17.7M$17.7M2020
Net income-$66.4M-$66.4M2020
Operating income-$36.0M-$36.0M2020
Total assets$24.4M$24.4M2020
Liabilities$33.3M$33.3M2020
Equity-$8.9M-$8.9M2020
Revenue trend
FY2017 – FY2020 · USD
FY17
FY18
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is ManifestSeven Holdings Corporation’s revenue?
ManifestSeven Holdings Corporation booked $17.7M in FY2020 revenue, growing 64% year over year — faster than most Healthcare companies we track, at a -374.3% net margin.
Peers · Healthcare
Trees Corporation——Marpai, Inc.34DResponse Genetics, Inc——Vibe Growth Corporation58CMicron Solutions, Inc.——Vivos Therapeutics, Inc.38DNeighbors
Orange →Key facts
CEOSturges J. Karban
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersIrvine, CA
ExchangeOTC: MNFSF
Employees14
IPO date2020-10-05
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.